Company Dossier · Consumer Staples
Kimberly-Clark
- S&P 500
- Russell 1000
What Kimberly-Clark is doing, read from its filings, its own words and the news, with every figure dated and sourced. Not investment advice: no ratings, no price targets.
Open the full company record in Palanor: guidance, KPIs, ownership, calls, prices →
The latest read
Computed from the data on Oct 22, 2026. Every figure links back to its source in the sections below.
- Revenue over the four quarters to June 30, 2026: $16.6 billion, up 0.7% from a year earlier.SEC EDGAR filings (XBRL)
- Free cash flow (operating cash flow minus capital expenditure) over the four quarters to June 30, 2026: $1.82 billion, down 13% from a year earlier.SEC EDGAR filings (XBRL)
- Capital expenditure over the four quarters to June 30, 2026: $1.51 billion, up 96% from a year earlier.SEC EDGAR filings (XBRL)
- Share buybacks in the fiscal year to December 31, 2025: $0.14 billion.SEC EDGAR filings (10-K)
- Latest earnings call or results release (August 6, 2026): sentiment 0.10 on a −1 to +1 scale (mixed), confidence 0.60 of 1.Palanor Discourse
- Latest annual report (filed February 12, 2026): 12 risk factors added, 2 removed.Risk Factor Changes (10-K Item 1A)
- Insiders were net sellers in Q2 2026: $0.7 million on the open market.SEC Form 4
- 1,721 institutional managers reported a position at June 30, 2026 (+63 on the quarter before).SEC Form 13F
- H-1B filings certified in Q2 2026: 18 (19 a year earlier).U.S. Department of Labor (OFLC)
Risk events (12 months): 1 — latest OSHA inspection, Jun 1, 2026 →
Company Posture
How Company Posture is measured →What Kimberly-Clark is doing, on three axes, from its filings and its own words, as of 2026-10-22. A description, not a rating: Company Posture never says whether to buy.
Expanding · Hedging
Expanding ↔ Retrenching
Expanding
- Capital spending95th pct
- Debt raised—
- Buybacks vs capex94th pct
- Hiring filings54th pct
- Deals and private raises49th pct
- Patent publications54th pct
Confident ↔ Hedging
Hedging
- Call sentiment20th pct
- Call confidence35th pct
- Guidance changes—
- Risk factors added6th pct
- Insider open-market trades33rd pct
- − Call sentiment
- − Risk factors added
- − Call confidence
Pressure
Components only: Not yet shown as a score: in the back-test it did not add to a naive reader's forecast of impairment, debt acceleration or bankruptcy filings (8-K 2.06, 2.04, 1.03) (not enough events (17 in half 1; needs 20)).
- Fails-to-deliver98th pct
- Stress filings36th pct
Credit
How these are built →Kimberly-Clark's borrowing from its SEC filings: the bonds it priced and the debt on its latest balance sheet. A description, not a rating.
Debt on the balance sheet
$6.5B
- Due within a year $0.0B
- Longer term $6.5B
- Default point $3.3B (short + ½ long)
Finance leases included · Jun 30, 2026 filing
Bonds priced, last 12 months
None
U.S. dollar tranches with a term sheet on EDGAR. Deals sold under Rule 144A file none and are not counted.
Charts
Live charts: each one redraws from today’s data and has an image link to paste into a document or slide.
Cash flow
Capital returned and raised
What the company says
Hiring and ownership
In the news
Headlines that name Kimberly-Clark, with the publisher and a link. The tone is read from each headline’s own words, never from a summary of the article.
- NeutralKimberly-Clark announces COO transition ahead of Kenvue deal (NASDAQ:KMB)
seekingalpha.com · via Marketaux · Oct 1, 2026
Filings and records
The last two years of notable 8-Ks, offerings, annual reports, federal awards, lobbying reports, patents and other public records, newest first.
- Oct 21, 2026LobbyingLobbying report (PRIME POLICY GROUP)third_quarter 2026 · $0.1 million
- Oct 20, 2026LobbyingLobbying report (KIMBERLY-CLARK CORPORATION)third_quarter 2026 · $0.9 million
- Oct 20, 2026LobbyingLobbying report (AKIN GUMP STRAUSS HAUER & FELD)third_quarter 2026 · $0.1 million
- Oct 20, 2026PatentPatent granted: HIGH POROSITY NON-WOOD PULPUS 12768107
- Oct 20, 2026Patent
- Oct 20, 2026Patent
- Oct 18, 2026LobbyingLobbying report (BALLARD PARTNERS)third_quarter 2026 · $0.2 million
- Oct 13, 2026Patent
- Oct 6, 2026Patent
- Oct 1, 20268-KDirector or officer changeItem 5.02
- Jul 20, 2026LobbyingLobbying report (KIMBERLY-CLARK CORPORATION)second_quarter 2026 · $0.7 million
- Jul 20, 2026LobbyingLobbying report (PRIME POLICY GROUP)second_quarter 2026 · $0.1 million
- Jul 20, 2026LobbyingLobbying report (AKIN GUMP STRAUSS HAUER & FELD)second_quarter 2026 · $0.1 million
- Jul 15, 2026LobbyingLobbying report (BALLARD PARTNERS)second_quarter 2026 · $0.2 million
- Jun 1, 2026Risk event
- May 14, 20268-KShareholder vote resultsItem 5.07
- May 5, 20268-KDirector or officer changeItem 5.02
- Feb 12, 202610-KAnnual report (10-K)12 risk factors added, 2 removed
- Jan 29, 20268-KShareholder vote resultsItem 5.07
- Nov 7, 20258-KDirector or officer changeItem 5.02
- Nov 3, 20258-KMaterial agreement signedItem 1.01
- May 19, 20258-KDelisting notice or listing transferItem 3.01
- May 6, 20258-KDirector or officer changeItem 5.02
- May 6, 20258-KDirector or officer changeItem 5.02
- May 2, 20258-KShareholder vote resultsItem 5.07
- Feb 13, 202510-KAnnual report (10-K)0 risk factors added, 0 removed
- Jan 28, 20258-KDirector or officer changeItem 5.02
- Nov 13, 20248-KDirector or officer changeItem 5.02
- Feb 8, 202410-KAnnual report (10-K)1 risk factors added, 0 removed
Peers
Companies in the same industry in the S&P 500, Russell 1000 or MidCap 400, closest in revenue first. Trailing twelve months, from SEC filings.
| Company | Revenue | Free cash flow | Through |
|---|---|---|---|
| Colgate-Palmolive CL | $21.1B | $3.9B | Jun 30, 2026 |
| Clorox CLX | $6.8B | $0.4B | Mar 31, 2026 |
| Church & Dwight CHD | $6.2B | — | Jun 30, 2026 |
| Procter & Gamble PG | $87.0B | $15.2B | Jun 30, 2026 |
| Smithfield Foods SFD | $15.5B | — | Jun 28, 2026 |
| Kenvue KVUE | $15.4B | $1.9B | Jun 28, 2026 |
| Bunge Global BG | $17.9B | −$1.2B | Mar 31, 2026 |
| Estée Lauder EL | $15.1B | $1.3B | Jun 30, 2026 |